Skip to main navigation Skip to main content
  • KSPTM
  • E-Submission

PHD : Parasites, Hosts and Diseases

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

5
results for

"DNA vaccine"

Article category

Keywords

Publication year

Authors

Funded articles

"DNA vaccine"

Original Articles

Evaluation of Protective Immune Response Induced by a DNA Vaccine Encoding GRA8 against Acute Toxoplasmosis in a Murine Model
Jia-Qi Chu, Shuai Huang, Wei Ye, Xuan-Yan Fan, Rui Huang, Shi-Cai Ye, Cai-Yuan Yu, Wei-Yun Wu, Yu Zhou, Wei Zhou, Young-Ha Lee, Juan-Hua Quan
Korean J Parasitol 2018;56(4):325-334.
Published online August 31, 2018
DOI: https://doi.org/10.3347/kjp.2018.56.4.325
Toxoplasma gondii is an apicomplexan zoonotic protozoan parasite that infects most species of warm-blooded animals, including humans. The heavy incidence and severe or lethal damage caused by T. gondii infection clearly indicate a need for the development of an effective vaccine. T. gondii GRA8 is a member of the dense granules protein family and is used as a marker of acute infection. In the present study, we evaluated the protective immunity induced by DNA vaccination based on a recombinant eukaryotic plasmid, pDsRed2-GRA8, against acute toxoplasmosis in mice. BALB/c mice were intramuscularly immunized with the pDsRed2-GRA8 plasmid and then challenged by infection with the highly virulent GFP-RH strain of T. gondii. The specific immune responses and protective efficacy against T. gondii of this vaccine were analyzed by measuring cytokine and serum antibody titers, splenocyte proliferation assays, and the survival times of mice after challenge. Our results showed that mice immunized with pDsRed2-GRA8 demonstrated specific humoral and cellular responses, induced higher IgG antibody titers with predominant IgG2a production; increased levels of IL-10, IL-12 (p70), IFN-γ, TNF-α, and splenocyte proliferation; and prolonged survival times compared to those of control mice. The present study showed that DNA immunization with pDsRed2-GRA8 induced humoral and cellular immune responses, and all immunized mice showed greater Th1-type immune responses and longer survival times than those of control mice. These results indicated that T. gondii GRA8 DNA immunization induces a partial protective effect against acute toxoplasmosis.

Citations

Citations to this article as recorded by  Crossref logo
  • Toxoplasma gondii vaccine candidates: a concise review
    Amirreza Javadi Mamaghani, Anwar Fathollahi, Zahra Arab-Mazar, Kobra kohansal, Matin Fathollahi, Adel Spotin, Homayoon Bashiri, Arezoo Bozorgomid
    Irish Journal of Medical Science (1971 -).2023; 192(1): 231.     CrossRef
  • Insight into the current Toxoplasma gondii DNA vaccine: a review article
    Xirui Zhang, Hao Yuan, Yasser S. Mahmmod, Zipeng Yang, Mengpo Zhao, Yining Song, Shengjun Luo, Xiu-Xiang Zhang, Zi-Guo Yuan
    Expert Review of Vaccines.2023; 22(1): 66.     CrossRef
  • Co-Immunization with DNA Vaccines Expressing SABP1 and SAG1 Proteins Effectively Enhanced Mice Resistance to Toxoplasma gondii Acute Infection
    Xiaoyu Sang, Xiang Li, Ran Chen, Ying Feng, Ting He, Xiaohan Zhang, Saeed El-Ashram, Ebtsam Al-Olayan, Na Yang
    Vaccines.2023; 11(7): 1190.     CrossRef
  • Evaluation of anti‐tick efficiency in rabbits induced by DNA vaccines encoding Haemaphysalis longicornis lipocalin homologue
    Xiang‐Yuan Fan, Xiao‐Can Xu, Ya‐Xue Wu, Xiao‐Ya Liu, Feng Yang, Yong‐Hong Hu
    Medical and Veterinary Entomology.2022; 36(4): 511.     CrossRef
  • Review of DNA Vaccine Approaches Against the Parasite Toxoplasma gondii
    Rosalie C. Warner, Ryan C. Chapman, Brianna N. Davis, Paul H. Davis
    Journal of Parasitology.2021;[Epub]     CrossRef
  • A systematic review on the role of GRA proteins of Toxoplasma gondii in host immunization
    Fatemeh Rezaei, Mahdi Sharif, Shahabeddin Sarvi, Seyed Hossein Hejazi, Sargis Aghayan, Abdol Sattar Pagheh, Samira Dodangeh, Ahmad Daryani
    Journal of Microbiological Methods.2019; 165: 105696.     CrossRef
  • 9,613 View
  • 172 Download
  • 8 Web of Science
  • Crossref
DNA Vaccines Encoding Toxoplasma gondii Cathepsin C 1 Induce Protection against Toxoplasmosis in Mice
Yali Han, Aihua Zhou, Gang Lu, Guanghui Zhao, Wenchao Sha, Lin Wang, Jingjing Guo, Jian Zhou, Huaiyu Zhou, Hua Cong, Shenyi He
Korean J Parasitol 2017;55(5):505-512.
Published online October 31, 2017
DOI: https://doi.org/10.3347/kjp.2017.55.5.505
Toxoplasma gondii cathepsin C proteases (TgCPC1, 2, and 3) are important for the growth and survival of T. gondii. In the present study, B-cell and T-cell epitopes of TgCPC1 were predicted using DNAstar and the Immune Epitope Database. A TgCPC1 DNA vaccine was constructed, and its ability to induce protective immune responses against toxoplasmosis in BALB/c mice was evaluated in the presence or absence of the adjuvant α-GalCer. As results, TgCPC1 DNA vaccine with or without adjuvant α-GalCer showed higher levels of IgG and IgG2a in the serum, as well as IL-2 and IFN-γ in the spleen compared to controls (PBS, pEGFP-C1, and α-Galcer). Upon challenge infection with tachyzoites of T. gondii (RH), pCPC1/α-Galcer immunized mice showed the longest survival among all the groups. Mice vaccinated with DNA vaccine without adjuvant (pCPC1) showed better protective immunity compared to other controls (PBS, pEGFP-C1, and α-Galcer). These results indicate that a DNA vaccine encoding TgCPC1 is a potential vaccine candidate against toxoplasmosis.

Citations

Citations to this article as recorded by  Crossref logo
  • Modest Protective Immune Responses Induced by a DNA Vaccine Expressing IMP1 of Toxoplasma gondii in BALB/c Mice
    Farid Alizadeh, Maryam Hataminejad, Hajar Yaghoobi, Hakim Azizi
    Parasite Immunology.2025;[Epub]     CrossRef
  • Insight into the current Toxoplasma gondii DNA vaccine: a review article
    Xirui Zhang, Hao Yuan, Yasser S. Mahmmod, Zipeng Yang, Mengpo Zhao, Yining Song, Shengjun Luo, Xiu-Xiang Zhang, Zi-Guo Yuan
    Expert Review of Vaccines.2023; 22(1): 66.     CrossRef
  • iNKT cell agonists as vaccine adjuvants to combat infectious diseases
    Ya-Qian Li, Cheng Yan, Rui Luo, Zheng Liu
    Carbohydrate Research.2022; 513: 108527.     CrossRef
  • Mining the Proteome of Toxoplasma Parasites Seeking Vaccine and Diagnostic Candidates
    Sajad Rashidi, Javier Sánchez-Montejo, Reza Mansouri, Mohammad Ali-Hassanzadeh, Amir Savardashtaki, Mohammad Saleh Bahreini, Mohammadreza Karimazar, Raúl Manzano-Román, Paul Nguewa
    Animals.2022; 12(9): 1098.     CrossRef
  • A Novel Combined DNA Vaccine Encoding Toxoplasma gondii SAG1 and ROP18 Provokes Protective Immunity Against a Lethal Challenge in Mice
    Lamei Wu, Huijian Yang, Jianglin Wang, Xiuwen Yu, Yanhong He, Shenxia Chen
    Acta Parasitologica.2021; 66(4): 1387.     CrossRef
  • Review of DNA Vaccine Approaches Against the Parasite Toxoplasma gondii
    Rosalie C. Warner, Ryan C. Chapman, Brianna N. Davis, Paul H. Davis
    Journal of Parasitology.2021;[Epub]     CrossRef
  • Characterization of metalloproteases and serine proteases of Toxoplasma gondii tachyzoites and their effect on epithelial cells
    Carlos J. Ramírez-Flores, Rosalba Cruz-Mirón, Rossana Arroyo, Mónica E. Mondragón-Castelán, Tais Nopal-Guerrero, Sirenia González-Pozos, Emmanuel Ríos-Castro, Ricardo Mondragón-Flores
    Parasitology Research.2019; 118(1): 289.     CrossRef
  • Antigenic Epitope Analysis and Efficacy Evaluation of GRA41 DNA Vaccine Against T. gondii Infection
    Jian Zhou, Chenxi Li, Yingquan Luo, Lin Wang
    Acta Parasitologica.2019; 64(3): 471.     CrossRef
  • Cysteine proteases in protozoan parasites
    Jair L. Siqueira-Neto, Anjan Debnath, Laura-Isobel McCall, Jean A. Bernatchez, Momar Ndao, Sharon L. Reed, Philip J. Rosenthal, Photini Sinnis
    PLOS Neglected Tropical Diseases.2018; 12(8): e0006512.     CrossRef
  • Immune Responses Induced by HSP60 DNA Vaccine against Toxoplasma gondii Infection in Kunming Mice
    Zhong-Yuan Li, Jing Lu, Nian-Zhang Zhang, Jia Chen, Xing-Quan Zhu
    The Korean Journal of Parasitology.2018; 56(3): 237.     CrossRef
  • Evaluation of Protective Immune Response Induced by a DNA Vaccine Encoding GRA8 against Acute Toxoplasmosis in a Murine Model
    Jia-Qi Chu, Shuai Huang, Wei Ye, Xuan-Yan Fan, Rui Huang, Shi-Cai Ye, Cai-Yuan Yu, Wei-Yun Wu, Yu Zhou, Wei Zhou, Young-Ha Lee, Juan-Hua Quan
    The Korean Journal of Parasitology.2018; 56(4): 325.     CrossRef
  • 11,067 View
  • 138 Download
  • 12 Web of Science
  • Crossref
Protective and Anti-Pathology Effects of Sm Fructose-1,6-Bisphosphate Aldolase-Based DNA Vaccine against Schistosoma mansoni by Changing Route of Injection
Mohamed Saber, Tarek Diab, Olft Hammam, Amr Karim, Amina Medhat, Mamdouh Khela, Ehab El-Dabaa
Korean J Parasitol 2013;51(2):155-163.
Published online April 25, 2013
DOI: https://doi.org/10.3347/kjp.2013.51.2.155

This study aimed to evaluate the efficacy of fructose-1,6-bis phosphate aldolase (SMALDO) DNA vaccination against Schistosoma mansoni infection using different routes of injection. The SMALDO has been cloned into the eukaryotic expression vector pcDNA3.1/V5-His TOPO-TA and was used in injecting Swiss albino mice intramuscularly (IM), subcutaneously (SC), or intraperitoneally (IP) (50 ?g/mouse). Mice vaccinated with non-recombinant pcDNA3.1 served as controls. Each group was immunized 4 times at weeks 0, 2, 4, and 6. Two weeks after the last booster dose, all mice groups were infected with 80 S. mansoni cercariae via tail immersion. At week 8 post-infection, animals were sacrificed for assessment of parasitological and histopathological parameters. High anti-SMALDO IgG antibody titers were detected in sera of all vaccinated groups (P<0.01) compared to the control group. Both the IP and SC vaccination routes resulted in a significant reduction in worm burden (46.2% and 28.9%, respectively, P<0.01). This was accompanied by a significant reduction in hepatic and intestinal egg counts (41.7% and 40.2%, respectively, P<0.01) in the IP group only. The number of dead eggs was significantly increased in both IP and IM groups (P<0.01). IP vaccination recorded the highest significant reduction in granuloma number and diameter (54.7% and 29.2%, respectively, P<0.01) and significant increase in dead miracidia (P<0.01). In conclusion, changing the injection route of SMALDO DNA vaccination significantly influenced the efficacy of vaccination. SMALDO DNA vaccination via IP route could be a promising protective and anti-pathology vaccine candidate against S. mansoni infection.

Citations

Citations to this article as recorded by  Crossref logo
  • Glycolytic Enzymes as Vaccines Against Schistosomiasis: Testing Schistosoma mansoni Phosphoglycerate Mutase in Mice
    David B. Pirovich, Akram A. Da'dara, Patrick J. Skelly
    Journal of Parasitology.2024;[Epub]     CrossRef
  • Multifunctional Fructose 1,6-Bisphosphate Aldolase as a Therapeutic Target
    David B. Pirovich, Akram A. Da’dara, Patrick J. Skelly
    Frontiers in Molecular Biosciences.2021;[Epub]     CrossRef
  • Characterization of Fructose-1,6-Bisphosphate Aldolase 1 of Echinococcus multilocularis
    Xuedong He, Jing Zhang, Yue Sun, Tianyan Lan, Xiaola Guo, Xiaoqiang Wang, Omnia M. Kandil, Mazhar Ayaz, Xuenong Luo, Houhui Song, Yadong Zheng
    Veterinary Sciences.2021; 9(1): 4.     CrossRef
  • Proteomic analysis of adult Schistosoma mekongi somatic and excretory-secretory proteins
    Onrapak Reamtong, Nattapon Simanon, Tipparat Thiangtrongjit, Yanin Limpanont, Phiraphol Chusongsang, Yupa Chusongsang, Songtham Anuntakarun, Sunchai Payungporn, Orawan Phuphisut, Poom Adisakwattana
    Acta Tropica.2020; 202: 105247.     CrossRef
  • Amelioration of type 1 diabetes by recombinant fructose-1,6-bisphosphate aldolase and cystatin derived from Schistosoma japonicum in a murine model
    Ke Yan, Bo Wang, Huabang Zhou, Qingli Luo, Jilong Shen, Yunxia Xu, Zhengrong Zhong
    Parasitology Research.2020; 119(1): 203.     CrossRef
  • Linking murine resistance to secondary cystic echinococcosis with antibody responses targeting Echinococcus granulosus tegumental antigens
    Sebastián Miles, Javier Magnone, Marek Cyrklaff, Paula Arbildi, Friedrich Frischknecht, Sylvia Dematteis, Gustavo Mourglia-Ettlin
    Immunobiology.2020; 225(3): 151916.     CrossRef
  • Interactome analysis of CD5 and CD6 ectodomains with tegumental antigens from the helminth parasite Echinococcus granulosus sensu lato
    Sebastián Miles, María Velasco-de-Andrés, Francisco Lozano, Gustavo Mourglia-Ettlin
    International Journal of Biological Macromolecules.2020; 164: 3718.     CrossRef
  • Protein extract from head-foot tissue of Oncomelania hupensis promotes the growth and development of mother sporocysts of Schistosoma japonicum via upregulation of parasite aldolase gene
    Ting Chai, Sijing Zhu, Huifen Dong, Zhenping Ming
    Parasitology Research.2019; 118(6): 1821.     CrossRef
  • Comparative study of excretory–secretory proteins released by Schistosoma mansoni-resistant, susceptible and naïve Biomphalaria glabrata
    Conor E. Fogarty, Min Zhao, Donald P. McManus, Mary G. Duke, Scott F. Cummins, Tianfang Wang
    Parasites & Vectors.2019;[Epub]     CrossRef
  • Why Do Intravascular Schistosomes Coat Themselves in Glycolytic Enzymes?
    David Pirovich, Akram A. Da'dara, Patrick J. Skelly
    BioEssays.2019;[Epub]     CrossRef
  • Schistosomiasis in Egypt: A never-ending story?
    Ahmad A. Othman, Rasha H. Soliman
    Acta Tropica.2015; 148: 179.     CrossRef
  • Cloning, expression, and partial characterization of FBPA from Schistosoma japonicum, a molecule on that the fluke may develop nutrition competition and immune evasion from human
    Qiping Hu, Huiqiong Xie, Shuyu Zhu, Dejun Liao, Tingzheng Zhan, Dengyu Liu
    Parasitology Research.2015; 114(9): 3459.     CrossRef
  • Evaluation of Echinostoma liei worm, metacercaria and redia antigens for schistosomiasis control
    G. Abdel-Monaem, A. Farid, I. Rabia, A. El-Amir
    Experimental Parasitology.2015; 157: 23.     CrossRef
  • 9,980 View
  • 72 Download
  • Crossref
Efficacy of a DNA Vaccine Carrying Eimeria maxima Gam56 Antigen Gene against Coccidiosis in Chickens
Jinjun Xu, Yan Zhang, Jianping Tao
Korean J Parasitol 2013;51(2):147-154.
Published online April 25, 2013
DOI: https://doi.org/10.3347/kjp.2013.51.2.147

To control coccidiosis without using prophylactic medications, a DNA vaccine targeting the gametophyte antigen Gam56 from Eimeria maxima in chickens was constructed, and the immunogenicity and protective effects were evaluated. The ORF of Gam56 gene was cloned into an eukaryotic expression vector pcDNA3.1(zeo)+. Expression of Gam56 protein in COS-7 cells transfected with recombinant plasmid pcDNA-Gam56 was confirmed by indirect immunofluorescence assay. The DNA vaccine was injected intramuscularly to yellow feathered broilers of 1-week old at 3 dosages (25, 50, and 100 ?g/chick). Injection was repeated once 1 week later. One week after the second injection, birds were challenged orally with 5×104 sporulated oocysts of E. maxima, then weighed and killed at day 8 post challenge. Blood samples were collected and examined for specific peripheral blood lymphocyte proliferation activity and serum antibody levels. Compared with control groups, the administration of pcDNA-Gam56 vaccine markedly increased the lymphocyte proliferation activity (P<0.05) at day 7 and 14 after the first immunization. The level of lymphocyte proliferation started to decrease on day 21 after the first immunization. A similar trend was seen in specific antibody levels. Among the 3 pcDNA-Gam56 immunized groups, the median dosage group displayed the highest lymphocyte proliferation and antibody levels (P<0.05). The median dosage group had the greatest relative body weight gain (89.7%), and the greatest oocyst shedding reduction (53.7%). These results indicate that median dosage of DNA vaccine had good immunogenicity and immune protection effects, and may be used in field applications for coccidiosis control.

Citations

Citations to this article as recorded by  Crossref logo
  • Alternatives to antibiotics against coccidiosis for poultry production: the relationship between immunity and coccidiosis management – a comprehensive review
    Mohamed T. El-Saadony, Heba M. Salem, Marwa M. Attia, Nahed Yehia, Ahmed H. Abdelkader, Sara Abdel Mawgod, Nesma Mohamed Kamel, Samar Sami Alkafaas, Muslimah N. Alsulami, Ahmed Ezzat Ahmed, Dina Mostafa Mohammed, Ahmed M. Saad, Walid F.A. Mosa, Shaaban S.
    Annals of Animal Science.2025;[Epub]     CrossRef
  • Insight into poultry coccidiosis: a dual focus on anticoccidial drugs and herbal plants for pharmacological and prevention strategies
    Pooja Bharti, Syed Tanveer, Zahoor Ahmad Wani, Shabir Ahmad Rather, Zahoor Ahmad Parray
    Journal of Parasitic Diseases.2025; 49(3): 565.     CrossRef
  • Development and immunological insights into recombinant/subunit vaccines against avian coccidiosis
    Shagufta Iqbal, Syed Tanveer, Idrees Mehraj Allaie, Yasmeena Jan, Shahana Tramboo, Nazima Maqbool
    Journal of Microbiological Methods.2025; 238: 107255.     CrossRef
  • Innovative prevention and control of coccidiosis: targeting sporogony for new control agent development
    Dan Zhao, Jingxia Suo, Lin Liang, Ruiying Liang, Rongqiong Zhou, Jiabo Ding, Xianyong Liu, Xun Suo, Sixin Zhang, Xinming Tang
    Poultry Science.2024; 103(12): 104246.     CrossRef
  • In vitro cultivation methods for coccidian parasite research
    Anna Sophia Feix, Teresa Cruz-Bustos, Bärbel Ruttkowski, Anja Joachim
    International Journal for Parasitology.2023; 53(9): 477.     CrossRef
  • Recombinant GMA56 and ROP17 of Eimeria magna conferred protection against infection by homologous species
    Jie Xiao, Hao Chen, Ruoyu Zheng, Jiayan Pu, Xiaobin Gu, Yue Xie, Ran He, Jing Xu, Bo Jing, Xuerong Peng, Guangyou Yang
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • What Do We Know about Surface Proteins of Chicken Parasites Eimeria?
    Jesica Daiana Britez, Anabel Elisa Rodriguez, Lucía Di Ciaccio, Virginia Marugán-Hernandez, Mariela Luján Tomazic
    Life.2023; 13(6): 1295.     CrossRef
  • Cloning, expression and purification of Eimeria maxima gametocyte antigen-EmGam56 for control of poultry coccidiosis
    Vijayashanthi Ramalingam, Raman Muthusamy, Kasthuri Bohra, Azhahianambi Palavesam, Dhinakarraj Gopal
    Journal of Parasitic Diseases.2023; 47(4): 773.     CrossRef
  • Vaccination Against Poultry Parasites
    Ruediger Hauck, Kenneth S. Macklin
    Avian Diseases.2023;[Epub]     CrossRef
  • Coccidiosis: Recent Progress in Host Immunity and Alternatives to Antibiotic Strategies
    Youngsub Lee, Mingmin Lu, Hyun S. Lillehoj
    Vaccines.2022; 10(2): 215.     CrossRef
  • A multiepitope vaccine encoding four Eimeria epitopes with PLGA nanospheres: a novel vaccine candidate against coccidiosis in laying chickens
    ZhengQing Yu, SiYing Chen, JianMei Huang, WenXi Ding, YuFeng Chen, JunZhi Su, RuoFeng Yan, LiXin Xu, XiaoKai Song, XiangRui Li
    Veterinary Research.2022;[Epub]     CrossRef
  • Vaccines against chicken coccidiosis with particular reference to previous decade: progress, challenges, and opportunities
    Tean Zaheer, Rao Zahid Abbas, Muhammad Imran, Asghar Abbas, Ali Butt, Sarfraz Aslam, Jameel Ahmad
    Parasitology Research.2022; 121(10): 2749.     CrossRef
  • Research progress of the avian coccidiosis vaccine
    Haiming Cai, Nanshan Qi, Juan Li, Minna Lv, Xuhui Lin, Junjing Hu, Jianfei Zhang, Shenquan Liao, Mingfei Sun
    Veterinary Vaccine.2022; 1(1): 100002.     CrossRef
  • Protection of hatchlings against coccidiosis by maternal antibodies to four recombinant proteins of Eimeria tenella, Eimeria acervulina and Eimeria maxima
    Xu Yang, Xingju Song, Jing Liu, Qingzhong Chen, Tongwei An, Qun Liu
    Veterinary Parasitology.2022; 312: 109813.     CrossRef
  • Veteriner protozoolojide aşı uygulamalarına güncel yaklaşım
    Ahmet GÖKSU, Hatice ÇİÇEK
    Journal of Advances in VetBio Science and Techniques.2021; 6(2): 179.     CrossRef
  • Brief History and Advancements of Vaccination Against Avian Coccidiosis: A Review

    Science Letters.2021; 9(2): 31.     CrossRef
  • Sexual Development in Non-Human Parasitic Apicomplexa: Just Biology or Targets for Control?
    Teresa Cruz-Bustos, Anna Sophia Feix, Bärbel Ruttkowski, Anja Joachim
    Animals.2021; 11(10): 2891.     CrossRef
  • Characterization of Cystoisospora suis sexual stages in vitro
    Anna Sophia Feix, Teresa Cruz-Bustos, Bärbel Ruttkowski, Anja Joachim
    Parasites & Vectors.2020;[Epub]     CrossRef
  • Immunoprophylactic evaluation of recombinant gametocyte 22 antigen of Eimeria tenella in broiler chickens
    Shafiya Imtiaz Rafiqi, Rajat Garg, Hira Ram, K. K. Reena, Mayurkumar Asari, Priyanka Kumari, V. R. Kundave, Mithilesh Singh, P. S. Banerjee
    Parasitology Research.2019; 118(3): 945.     CrossRef
  • A review of Eimeria antigen identification for the development of novel anticoccidial vaccines
    J. Venkatas, M. A. Adeleke
    Parasitology Research.2019; 118(6): 1701.     CrossRef
  • Optimization of Immunization Procedure for Eimeria tenella DNA Vaccine pVAX1-pEtK2-IL-2 and Its Stability
    Bucai Zhang, Cheng Yuan, Xiaokai Song, Lixin Xu, Ruofeng Yan, Muhammad Ali A. Shah, Changming Guo, Shanyuan Zhu, Xiangrui Li
    Acta Parasitologica.2019; 64(4): 745.     CrossRef
  • Recent advances in delivery of veterinary DNA vaccines against avian pathogens
    Seyed Davoud Jazayeri, Chit Laa Poh
    Veterinary Research.2019;[Epub]     CrossRef
  • Passive immunization with Eimeria tenella gametocyte antigen 56 (EtGAM56) specific antibodies and active immunization trial with the epitope containing peptide
    Stefanie Wiedmer, Alaa Aldin Alnassan, Beate Volke, Ahmed Thabet, Arwid Daugschies, Matthias Lendner, Michael Kurth
    Veterinary Parasitology.2017; 247: 100.     CrossRef
  • Recombinant anticoccidial vaccines - a cup half full?
    Damer P. Blake, Iván Pastor-Fernández, Matthew J. Nolan, Fiona M. Tomley
    Infection, Genetics and Evolution.2017; 55: 358.     CrossRef
  • DNA vaccination of poultry: The current status in 2015
    Marine Meunier, Marianne Chemaly, Daniel Dory
    Vaccine.2016; 34(2): 202.     CrossRef
  • Development of immunization trials against Eimeria spp.
    Tarek A. Ahmad, Bassant A. El-Sayed, Laila H. El-Sayed
    Trials in Vaccinology.2016; 5: 38.     CrossRef
  • Construction of Eimeria tenella multi-epitope DNA vaccines and their protective efficacies against experimental infection
    Xiaokai Song, Lixin Xu, Ruofeng Yan, Xinmei Huang, Xiangrui Li
    Veterinary Immunology and Immunopathology.2015; 166(3-4): 79.     CrossRef
  • Immunization with recombinant 3-1E protein in AbISCO®-300 adjuvant induced protective immunity against Eimeria acervulina infection in chickens
    Ying Zhang, Lixia Wang, Wenke Ruan, Jianjun Zhang, Peng Yao, Sai Zhou, Jian An
    Experimental Parasitology.2014; 141: 75.     CrossRef
  • Securing poultry production from the ever-present Eimeria challenge
    Damer P. Blake, Fiona M. Tomley
    Trends in Parasitology.2014; 30(1): 12.     CrossRef
  • Strategies for anti-coccidial prophylaxis
    DAVID M. WITCOMBE, NICHOLAS C. SMITH
    Parasitology.2014; 141(11): 1379.     CrossRef
  • 9,870 View
  • 107 Download
  • Crossref
Brief Communication
CD8+ T-cell Activation in Mice Injected with a Plasmid DNA Vaccine Encoding AMA-1 of the Reemerging Korean Plasmodium vivax
Hyo-Jin Kim, Bong-Kwang Jung, Jin-Joo Lee, Kyoung-Ho Pyo, Tae Yun Kim, Byung-il Choi, Tae Woo Kim, Hajime Hisaeda, Kunisuke Himeno, Eun-Hee Shin, Jong-Yil Chai
Korean J Parasitol 2011;49(1):85-90.
Published online March 18, 2011
DOI: https://doi.org/10.3347/kjp.2011.49.1.85

Relatively little has been studied on the AMA-1 vaccine against Plasmodium vivax and on the plasmid DNA vaccine encoding P. vivax AMA-1 (PvAMA-1). In the present study, a plasmid DNA vaccine encoding AMA-1 of the reemerging Korean P. vivax has been constructed and a preliminary study was done on its cellular immunogenicity to recipient BALB/c mice. The PvAMA-1 gene was cloned and expressed in the plasmid vector UBpcAMA-1, and a protein band of approximately 56.8 kDa was obtained from the transfected COS7 cells. BALB/c mice were immunized intramuscularly or using a gene gun 4 times with the vaccine, and the proportions of splenic T-cell subsets were examined by fluorocytometry at week 2 after the last injection. The spleen cells from intramuscularly injected mice revealed no significant changes in the proportions of CD8+ T-cells and CD4+ T-cells. However, in mice immunized using a gene gun, significantly higher (P<0.05) proportions of CD8+ cells were observed compared to UB vector-injected control mice. The results indicated that cellular immunogenicity of the plasmid DNA vaccine encoding AMA-1 of the reemerging Korean P. vivax was weak when it was injected intramuscularly; however, a promising effect was observed using the gene gun injection technique.

Citations

Citations to this article as recorded by  Crossref logo
  • Live Vaccination with Blood-Stage Plasmodium yoelii 17XNL Prevents the Development of Experimental Cerebral Malaria
    Takashi Imai, Ha Ngo-Thanh, Kazutomo Suzue, Aoi Shimo, Akihiro Nakamura, Yutaka Horiuchi, Hajime Hisaeda, Takashi Murakami
    Vaccines.2022; 10(5): 762.     CrossRef
  • Immunotherapeutic Effects of Different Doses of Mycobacterium tuberculosis ag85a/b DNA Vaccine Delivered by Electroporation
    Yan Liang, Lei Cui, Li Xiao, Xiao Liu, Yourong Yang, Yanbo Ling, Tong Wang, Lan Wang, Jie Wang, Xueqiong Wu
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Long-Term Humoral and Cellular Immune Responses Elicited by a Heterologous Plasmodium vivax Apical Membrane Antigen 1 Protein Prime/Adenovirus Boost Immunization Protocol
    Leoneide Érica Maduro Bouillet, Mariana Oliveira Dias, Natália Alves Dorigo, Andrew Douglas Moura, Bruce Russell, Francois Nosten, Laurent Renia, Érika Martins Braga, Ricardo Tostes Gazzinelli, Maurício M. Rodrigues, Irene S. Soares, Oscar Bruna-Romero, J
    Infection and Immunity.2011; 79(9): 3642.     CrossRef
  • 9,855 View
  • 74 Download
  • Crossref